EVA MARÍA
CIRUELOS GIL
Profesora asociada de Ciencias de la Salud
GlaxoSmithKline (United Kingdom)
Londres, Reino UnidoPublicaciones en colaboración con investigadores/as de GlaxoSmithKline (United Kingdom) (2)
2015
-
CEREBEL (EGF111438): A phase III, randomized, open-label study of lapatinib plus capecitabine versus trastuzumab plus capecitabine in patients with human epidermal growth factor receptor 2-positive metastatic breast cancer
Journal of Clinical Oncology, Vol. 33, Núm. 14, pp. 1564-1573
2009
-
Multicenter phase II study of lapatinib in patients with brain metastases from HER2-positive breast cancer
Clinical Cancer Research, Vol. 15, Núm. 4, pp. 1452-1459